Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms

Open access
SHIMIZU, WATARU, MATSUO, KIYOTAKA, TAKAGI, MASAHIKO, TANABE, YASUKO, AIBA, TAKESI, TAGUCHI, ATSUSHI, SUYAMA, KAZUHIRO, KURITA, TAKASHI, AIHARA, NAOHIKO, KAMAKURA, SHIRO·2000·Journal of Cardiovascular Electrophysiology

Abstract

ST Elevation in Brugada Syndrome. Introduction: Body surface distribution and magnitude of ST segment elevation and their reflection in 12‐lead ECGs have not been clarified in Brugada syndrome. Methods and Results: Eighty‐seven‐lead body surface potential mapping and 12‐lead ECGs were recorded simultaneously in 25 patients with Brugada syndrome and 40 control patients. The amplitude of the ST segment 20 msec after the end of QRS (ST20) was measured from all 87 leads, and an ST isopotential map was constructed. The maximum ST elevation (maxST20) was distributed in an area of the right ventricular outflow tract in all Brugada patients, and it was larger than that in control patients (0.37 ± 0.13 vs 0.12 ± 0.04 mV; P < 0.0005). The maximum was observed on the level of the parasternal fourth intercostal space, on which the VI and V2 leads of the standard 12‐lead ECG were located, in 18 of the 25 Brugada patients in whom typical coved‐ or saddleback type ST elevation was seen in leads VI and V2. The maximum was located on the second intercostals space in the remaining seven Brugada patients in whom only a mild saddleback‐type ST elevation was seen in leads V1 and V2 of the 12‐lead ECG. Typical ST segment elevation was recognized in leads V1 and V2, which were recorded on the second or third intercostal space. ST elevation in Brugada patients was dramatically normalized by isoproterenol, a β‐adrenergic agonist (maxST20 = 0.17 ± 0.08 mV; P < 0.0005 vs control conditions), and accentuated by disopyramide, an Na+ channel blocker (maxST20 = 0.50 ± 0.15 mV; P < 0.0005 vs control conditions), without any change in the location of the maxST20. Conclusion: Our data indicate that recordings of leads V1‐V3 of the 12‐lead ECG on the parasternal second or third intercostal space would be helpful in diagnosing suspected patients with Brugada syndrome. The data suggest that Na+ channel blockers are capable of accentuating ST elevation in leads V1‐V3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2000.tb00334.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 256

Metadata

Authors
SHIMIZU, W., MATSUO, K., TAKAGI, M., TANABE, Y., AIBA, T., TAGUCHI, A., SUYAMA, K., KURITA, T., AIHARA, N., & KAMAKURA, S.
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2000-04
Volume
11
Issue
4
Pages
396-404
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W1989115606
Cited by
256
References
19
FWCI
7.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms. https://app.cochat.ai/papers/10.1111/j.1540-8167.2000.tb00334.x
The paper
SHIMIZU, W., MATSUO, K., TAKAGI, M., TANABE, Y., AIBA, T., TAGUCHI, A., SUYAMA, K., KURITA, T., AIHARA, N., & KAMAKURA, S. (2000). Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/j.1540-8167.2000.tb00334.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.